Results 21 to 30 of about 8,109 (242)
Pregnancy outcomes in women with a hemoglobinopathy trait: a multicenter, retrospective study [PDF]
, 2021 Purpose To determine the risk of adverse maternal and neonatal outcomes in pregnant women with a hemoglobinopathy trait. Materials and methods Retrospective cohort study was conducted to compare adverse maternal and neonatal outcomes between ...
Amstad Bencaiova, Gabriela; https://orcid.org/ +3 more
core +1 more source
Red blood cell parameters in antenatal nonsickling hemoglobinopathy screening [PDF]
, 2015 Gabriela Bencaiova, Kristina Dapoto, Roland Zimmermann, Alexander Krafft Department of Obstetrics and Gynecology, Institute of Obstetric Research, University Hospital Zurich, Zurich, Switzerland Objective: To find a hematological parameter and the
Zimmermann R +3 more
core +2 more sources
Distribution of Hemoglobinopathy in Nepalese Population
Journal of Nepal Health Research Council, 2020 Background: Sickle cell and thalassemia are the inherited disorders of globin chain synthesis, and are the most common monogenic disease worldwide. This study aims to find the distribution of hemoglobinopathies (sickle cell and thalassemia) cases in ...
Rekha Manandhar Shrestha +5 more
doaj +1 more source
Scientific Reports, 2022 Ferritin is frequently used to screen some dire consequences of iron overload in β-thalassemia patients. The study aimed to define the best cutoff point of ferritin to screen for cardiac and liver hemosiderosis in these cases.
Hadi Darvishi-Khezri +7 more
doaj +1 more source
Time to Do Something for Vitamin D Deficiency; A Review
Journal of Pediatrics Review, 2015 Context: Vitamin D deficiency is a common nutritional disorder in Iran. Vitamin D is an essential health factor from birth onward. This study was conducted to summarize epidemiologic researches regarding vitamin D deficiency in different parts of the ...
Mehrnoush Kosaryan +3 more
doaj +3 more sources
Bromhexine is a potential drug for COVID-19; From hypothesis to clinical trials
Вопросы вирусологии, 2022 COVID-19 (novel coronavirus disease 2019), caused by the SARS-CoV-2 virus, has various clinical manifestations and several pathogenic pathways. Although several therapeutic options have been used to control COVID-19, none of these medications have been ...
S. Bahadoram +6 more
doaj +1 more source
Experiences, Attitudes, and Knowledge within the Hemoglobinopathy Community [PDF]
, 2022 Hemoglobinopathies are highly prevalent conditions, with a global carrier rate of about 7%, and where carriers often present with microcytic anemia. Despite this, a standard of care or treatment is not yet established for cases of hemoglobinopathies ...
Klinder, Anusha Beth
core
Hematology Reports, 2018 Beta thalassemia dominant results from mutations in the β globin chain gene resulting in the production of elongated, highly unstable beta globin chains.
Alexandra Agapidou +3 more
doaj +1 more source
HPLC Market Trends Advancements in HbA1C Hemoglobinopathy Testing for USA Point-of-Care
, 2023 HPLC Market Trends Advancements in HbA1C Hemoglobinopathy Testing for USA Point-of ...
Rahul Jagtap (16753542)
core +1 more source
Treatment Status of Patients with Β-Thalassemia Major in Northern Iran: Thalassemia Registry System
Iranian Journal of Public Health, 2019 Background: Electronic registry system of beta-thalassemia patients was run by Thalassemia Research Center (TRC) in 2017. The aim of the current study was presentation of therapeutic status in these patients at Mazandaran Province, Iran.
Mehrnoush KOSARYAN +5 more
doaj +1 more source